Mick D. Edmonds, Ph.D. - Publications

2016- Genetics University of Alabama Birmingham School of Medicine, Birmingham, AL, United States 

13 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Thompson MA, Edmonds MD, Liang S, McClintock-Treep S, Wang X, Li S, Eischen CM. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Human Pathology. 50: 118-26. PMID 26997445 DOI: 10.1016/j.humpath.2015.11.011  0.32
2015 Edmonds MD, Boyd KL, Moyo T, Mitra R, Duszynski R, Arrate MP, Chen X, Zhao Z, Blackwell TS, Andl T, Eischen CM. MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer. The Journal of Clinical Investigation. PMID 26657862 DOI: 10.1172/JCI82720  0.32
2014 Edmonds MD, Eischen CM. Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse. Plos One. 9: e101802. PMID 25028925 DOI: 10.1371/journal.pone.0101802  0.32
2014 Mitra R, Edmonds MD, Sun J, Zhao M, Yu H, Eischen CM, Zhao Z. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer. Rna (New York, N.Y.). 20: 1356-68. PMID 25024357 DOI: 10.1261/rna.042754.113  0.32
2013 Hurst DR, Xie Y, Thomas JW, Liu J, Edmonds MD, Stewart MD, Welch DR. The C-terminal putative nuclear localization sequence of breast cancer metastasis suppressor 1, BRMS1, is necessary for metastasis suppression. Plos One. 8: e55966. PMID 23390556 DOI: 10.1371/journal.pone.0055966  0.32
2012 Cook LM, Cao X, Dowell AE, Debies MT, Edmonds MD, Beck BH, Kesterson RA, Desmond RA, Frost AR, Hurst DR, Welch DR. Ubiquitous Brms1 expression is critical for mammary carcinoma metastasis suppression via promotion of apoptosis. Clinical & Experimental Metastasis. 29: 315-25. PMID 22241150 DOI: 10.1007/s10585-012-9452-x  0.32
2012 Bodenstine TM, Vaidya KS, Ismail A, Beck BH, Diers AR, Edmonds MD, Kirsammer GT, Landar A, Welch DR. Subsets of ATP-sensitive potassium channel (KATP) inhibitors increase gap junctional intercellular communication in metastatic cancer cell lines independent of SUR expression. Febs Letters. 586: 27-31. PMID 22119728 DOI: 10.1016/j.febslet.2011.11.017  0.32
2009 Hurst DR, Edmonds MD, Welch DR. Metastamir: the field of metastasis-regulatory microRNA is spreading. Cancer Research. 69: 7495-8. PMID 19773429 DOI: 10.1158/0008-5472.CAN-09-2111  0.32
2009 Edmonds MD, Hurst DR, Welch DR. Linking metastasis suppression with metastamiR regulation. Cell Cycle (Georgetown, Tex.). 8: 2673-5. PMID 19690456 DOI: 10.3779/j.issn.1009-3419.2010.02.12  0.32
2009 Frolova N, Edmonds MD, Bodenstine TM, Seitz R, Johnson MR, Feng R, Welch DR, Frost AR. A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Tumour Biology : the Journal of the International Society For Oncodevelopmental Biology and Medicine. 30: 148-59. PMID 19609101 DOI: 10.1159/000228908  0.32
2009 Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, Welch DR. Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. International Journal of Cancer. Journal International Du Cancer. 125: 1778-85. PMID 19585508 DOI: 10.1002/ijc.24616  0.32
2009 Hurst DR, Edmonds MD, Scott GK, Benz CC, Vaidya KS, Welch DR. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Research. 69: 1279-83. PMID 19190326 DOI: 10.1158/0008-5472.CAN-08-3559  0.32
2009 Hurst DR, Xie Y, Edmonds MD, Welch DR. Multiple forms of BRMS1 are differentially expressed in the MCF10 isogenic breast cancer progression model. Clinical & Experimental Metastasis. 26: 89-96. PMID 18841483 DOI: 10.1007/s10585-008-9216-9  0.32
Show low-probability matches.